Patent intelligence · US
US 11505572
Therapeutics for the treatment of glaucoma
Therapeutics for the treatment of glaucoma
Patent details — US 11505572
- Jurisdiction
- US
- Status
- granted
- Grant date
- Nov 22, 2022
- Expiration
- Nov 17, 2042
- Applicant
- Regents of the University of Minnesota
- Claims
- 37
- CPC classes
- A61K, A61K31/353, A61K31/4025, A61K31/4439
Quick answer
US 11505572 (Therapeutics for the treatment of glaucoma) is held by Regents of the University of Minnesota. Status: granted. Granted Nov 22, 2022. Expires Nov 17, 2042 (16 years remaining) — relevant for patent-cliff and LOE planning.
Key facts
- Applicant
- Regents of the University of Minnesota
- Grant date
- Expiration
- Claims
- 37
- CPC classes
- A61K, A61K31/353, A61K31/4025, A61K31/4439, A61K31/454, A61K31/549
More from Regents of the University of Minnesota
Related pharmaceutical patents in our USPTO index.
-
US 12428463
Chimeric antigen receptors targeting abnormal glycobiology
granted -
US 12427148
Cancer treatment targeted to tumor adaptive responses to protein synthesis stress
granted -
US 12428416
ERK inhibitors and uses thereof
granted -
US 12427151
Compositions and method of treating cancer
granted -
US 12427197
Methods of producing cobalt nanoparticles and hollow metal nanospheres
granted -
US 12428489
Human PD-L2 antibodies and methods of use therefor
granted -
US 12427155
Treatment for tau-related diseases
granted -
US 12428455
Dominant negative CEBPB and CEBPD proteins and methods of use for decreasing viability of neoplastic cells
granted
Frequently asked questions
What is US patent 11505572?
US 11505572 (Therapeutics for the treatment of glaucoma) is held by Regents of the University of Minnesota. Status: granted. Granted Nov 22, 2022. Expires Nov 17, 2042 (16 years remaining) — relevant for patent-cliff and LOE planning.
Who owns US 11505572?
Regents of the University of Minnesota is listed as the applicant in USPTO PatentsView records indexed by NovaPharmaNews. We track 8,292 pharmaceutical patents for this assignee.
When does US 11505572 expire?
Our index shows an expiration date of Nov 17, 2042 (16 years from today). Confirm material dates against USPTO, FDA Orange Book, or qualified counsel before contractual decisions.